VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma.
Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma. J Thorac Oncol. 2022 06; 17(6):779-792.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
ErbB Receptors
Humans
Kelch-Like ECH-Associated Protein 1
Lung Neoplasms
Mutation
NF-E2-Related Factor 2
Protein Kinase Inhibitors
Retrospective Studies
Tumor Suppressor Protein p53
authors with profiles
JOHN VICTOR HEYMACH